Medtronic launches Resolute Integrity DES in EU

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon
Medtronic has launched in Europe its Resolute Integrity drug-eluting stent (DES) system for the treatment of coronary artery disease, after receiving the CE mark.

Based on the engineering of continuous sinusoid technology, the Resolute Integrity DES is coupled with the MicroTrac delivery system. The Resolute Integrity DES combines continuous sinusoid technology with elements of the original Resolute DES: the cytostatic antiproliferative drug zotarolimus and the BioLinx polymer.